152 related articles for article (PubMed ID: 8894618)
81. Adaptations to chronic agonist exposure of mu-opioid receptor-expressing Chinese hamster ovary cells.
Kato S; Fukuda K; Morikawa H; Shoda T; Mima H; Mori K
Eur J Pharmacol; 1998 Mar; 345(2):221-8. PubMed ID: 9600641
[TBL] [Abstract][Full Text] [Related]
82. The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant mu-opioid receptors and SH-SY5Y cells.
Harrison C; McNulty S; Smart D; Rowbotham DJ; Grandy DK; Devi LA; Lambert DG
Br J Pharmacol; 1999 Sep; 128(2):472-8. PubMed ID: 10510460
[TBL] [Abstract][Full Text] [Related]
83. Effect of opioid receptor agonists on nitric oxide synthase activity in rat cerebral cortex homogenate.
Barjavel MJ; Bhargava HN
Neurosci Lett; 1994 Nov; 181(1-2):27-30. PubMed ID: 7534892
[TBL] [Abstract][Full Text] [Related]
84. Syntheses of potent Leu-enkephalin analogs possessing beta-hydroxy-alpha,alpha-disubstituted-alpha-amino acid and their characterization to opioid receptors.
Horikawa M; Shigeri Y; Yumoto N; Yoshikawa S; Nakajima T; Ohfune Y
Bioorg Med Chem Lett; 1998 Aug; 8(15):2027-32. PubMed ID: 9873480
[TBL] [Abstract][Full Text] [Related]
85. Highly selective kappa opioid analgesics. 4. Synthesis of some conformationally restricted naphthalene derivatives with high receptor affinity and selectivity.
Halfpenny PR; Horwell DC; Hughes J; Humblet C; Hunter JC; Neuhaus D; Rees DC
J Med Chem; 1991 Jan; 34(1):190-4. PubMed ID: 1846919
[TBL] [Abstract][Full Text] [Related]
86. Characterization of the murine mu opioid receptor gene.
Kaufman DL; Keith DE; Anton B; Tian J; Magendzo K; Newman D; Tran TH; Lee DS; Wen C; Xia YR
J Biol Chem; 1995 Jun; 270(26):15877-83. PubMed ID: 7797593
[TBL] [Abstract][Full Text] [Related]
87. Morphine-6-glucuronide, a potent mu agonist.
Pasternak GW; Bodnar RJ; Clark JA; Inturrisi CE
Life Sci; 1987 Dec; 41(26):2845-9. PubMed ID: 2826951
[TBL] [Abstract][Full Text] [Related]
88. Affinities of dihydrocodeine and its metabolites to opioid receptors.
Schmidt H; Vormfelde Sv; Klinder K; Gundert-Remy U; Gleiter CH; Skopp G; Aderjan R; Fuhr U
Pharmacol Toxicol; 2002 Aug; 91(2):57-63. PubMed ID: 12420793
[TBL] [Abstract][Full Text] [Related]
89. Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position.
Oguri K; Yamada-Mori I; Shigezane J; Hirano T; Yoshimura H
Life Sci; 1987 Sep; 41(12):1457-64. PubMed ID: 3041142
[TBL] [Abstract][Full Text] [Related]
90. Na+-dependent high affinity binding of [3H]LY515300, a 3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid receptor inverse agonist.
Statnick MA; Suter TM; Gackenheimer SL; Emmerson PJ; Quimby SJ; Gehlert DR; Wheeler WJ; Mitch CH
Eur J Pharmacol; 2003 Dec; 482(1-3):139-50. PubMed ID: 14660015
[TBL] [Abstract][Full Text] [Related]
91. Altered microviscosity at brain membrane surface induces distinct and reversible inhibition of opioid receptor binding.
Lazar DF; Medzihradsky F
J Neurochem; 1992 Oct; 59(4):1233-40. PubMed ID: 1328516
[TBL] [Abstract][Full Text] [Related]
92. Irreversible binding of N-methyl-N-[(1S)-1-(4-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl-3,4 -dichlorophenylacetamide to the cloned rat kappa opioid receptor.
Chen C; Yin J; Li JG; Xue JC; Weerawarna SA; Nelson WL; Liu-Chen LY
Life Sci; 1997; 61(8):787-94. PubMed ID: 9275008
[TBL] [Abstract][Full Text] [Related]
93. Altered amounts of G-protein mRNA and cAMP accumulation after long-term opioid receptor stimulation of neurons in primary culture from the rat cerebral cortex.
Eriksson PS; Carlsson B; Isaksson OG; Hansson E; Rönnbäck L
Brain Res Mol Brain Res; 1992 Aug; 14(4):317-25. PubMed ID: 1382177
[TBL] [Abstract][Full Text] [Related]
94. Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding.
Ni Q; Xu H; Partilla JS; de Costa BR; Rice KC; Borsodi A; Hosztafi S; Rothman RB
Neurochem Res; 1994 Sep; 19(9):1159-63. PubMed ID: 7824069
[TBL] [Abstract][Full Text] [Related]
95. In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile.
Kuo A; Magiera J; Rethwan N; Andersson Å; Leen Lam A; Wyse B; Meutermans W; Lewis R; Smith M
Eur J Pharmacol; 2020 Apr; 872():172947. PubMed ID: 31991138
[TBL] [Abstract][Full Text] [Related]
96. Univalent and bivalent ligands of butorphan: characteristics of the linking chain determine the affinity and potency of such opioid ligands.
Decker M; Fulton BS; Zhang B; Knapp BI; Bidlack JM; Neumeyer JL
J Med Chem; 2009 Dec; 52(23):7389-96. PubMed ID: 19634902
[TBL] [Abstract][Full Text] [Related]
97. Synthesis and opioid activity of 7-oxygenated 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolin-9-ols.
Cheng CY; Hsin LW; Tsai MC; Schmidt WK; Smith C; Tam SW
J Med Chem; 1994 Sep; 37(19):3121-7. PubMed ID: 7932535
[TBL] [Abstract][Full Text] [Related]
98. Conformational characteristics of opioid kappa-receptor agonist: crystal structure of (5S,7S,8S)-(-)-N-methyl-N-[7-(1-pyrrolidinyl)-1- oxaspiro[4.5]dec-8-yl]benzeneacetamide (U69,593), and conformational comparison with some kappa-agonists.
Doi M; Ishida T; Inoue M
Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1815-8. PubMed ID: 2176574
[TBL] [Abstract][Full Text] [Related]
99. Expressed mu opiate receptor couples to adenylate cyclase and phosphatidyl inositol turnover.
Johnson PS; Wang JB; Wang WF; Uhl GR
Neuroreport; 1994 Jan; 5(4):507-9. PubMed ID: 8003685
[TBL] [Abstract][Full Text] [Related]
100. Enantioselective kappa opioid binding sites on the macrophage cell line, P388d1.
Carr DJ; DeCosta BR; Jacobson AE; Rice KC; Blalock JE
Life Sci; 1991; 49(1):45-51. PubMed ID: 1646923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
